110 related articles for article (PubMed ID: 38796381)
21. Re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
Zhang M; Wang L
Eur Urol; 2020 Jun; 77(6):e161-e162. PubMed ID: 32303382
[No Abstract] [Full Text] [Related]
22. Reply to Luca Sarchi, Maria Chiara Sighinolfi, Simone Assumma, et al.'s Letter to Editor re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.01.008.
Bravi CA; Mottrie A
Eur Urol Focus; 2023 Sep; 9(5):843. PubMed ID: 36898944
[No Abstract] [Full Text] [Related]
23. Re: Baojun Wang, Qingbo Huang, Kan Liu, et al. Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.04.019: Robotic-assisted Laparoscopic Radical Nephrectomy and Tumor Thrombectomy: Is It Exclusively the Approach that Matters?
González J; Ciancio G
Eur Urol; 2020 Mar; 77(3):e72-e73. PubMed ID: 31543364
[No Abstract] [Full Text] [Related]
24. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
Samaratunga H; Delahunt B; Egevad L
Eur Urol; 2022 Jul; 82(1):e15-e16. PubMed ID: 35428506
[No Abstract] [Full Text] [Related]
25. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
Lei Y; Han S; Xing N
Eur Urol; 2022 May; 81(5):e121. PubMed ID: 35125229
[No Abstract] [Full Text] [Related]
26. Re: Annika Herlemann, Janet E. Cowan, Samuel L. Washington 3rd, et al. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.09.024.
Cussenot O; Chambaz A; Hamdy FC
Eur Urol; 2024 Mar; ():. PubMed ID: 38492978
[No Abstract] [Full Text] [Related]
27. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
Marra G; Stabile A; Gontero P; Montorsi F; Briganti A; Gandaglia G;
Eur Urol; 2022 May; 81(5):e115-e116. PubMed ID: 35151511
[No Abstract] [Full Text] [Related]
28. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039.
Alongi F; Aiello D; Mazzola R; Cavalleri S
Eur Urol; 2017 Aug; 72(2):e39-e40. PubMed ID: 28318727
[No Abstract] [Full Text] [Related]
29. Reply to Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.005: Salvage Robotic Radical Prostatectomy for Recurrence After Focal Therapy-The Truth and Consequences.
Patel V; Bhat KRS; Moschovas MC; Noel J; Rogers T
Eur Urol Focus; 2022 Nov; 8(6):1864. PubMed ID: 35219650
[No Abstract] [Full Text] [Related]
30. Reply to Mengda Zhang and Long Wang's Letter to the Editor re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
Amparore D; Checcucci E; Fiori C; Porpiglia F
Eur Urol; 2020 Jun; 77(6):e163-e164. PubMed ID: 32279902
[No Abstract] [Full Text] [Related]
31. Re: Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, et al. costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.059.
Rassweiler J
Eur Urol; 2013 Apr; 63(4):e53-6. PubMed ID: 23312570
[No Abstract] [Full Text] [Related]
32. Re: Loc Trinh, Samuel Mingo, Erik B. Vanstrum, et al. Survival Analysis Using Surgeon Skill Metrics and Patient Factors to Predict Urinary Continence Recovery After Robot-assisted Radical Prostatectomy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.04.001.
Grivas N; Kalampokis N; van der Poel H
Eur Urol Focus; 2022 Sep; 8(5):1186. PubMed ID: 34226160
[No Abstract] [Full Text] [Related]
33. Re: Andrea Gallioli, Angelo Territo, Romain Boissier, et al. Learning Curve in Robotic-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.008.
Yao J; Pleass HCC; Lau HMH
Eur Urol; 2020 Jun; 77(6):e165. PubMed ID: 32312545
[No Abstract] [Full Text] [Related]
34. Reply to Francesco Montorsi, Giorgio Gandaglia, Federico Dehò, Elio Mazzone, Armando Stabile, and Alberto Briganti's Letter to the Editor re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al. Early Catheter Removal on Postoperative Day 2 After Robot-assisted Radical Prostatectomy: Updated Real-life Experience with the Aalst Technique. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.003.
Develtere D; Bravi CA; Mottrie A
Eur Urol Focus; 2022 Nov; 8(6):1862-1863. PubMed ID: 35315318
[No Abstract] [Full Text] [Related]
35. Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002.
Ates F; Akyol I; Soydan H
Eur Urol; 2012 Jul; 62(1):e9; author reply e10-1. PubMed ID: 22512903
[No Abstract] [Full Text] [Related]
36. Re: Jordan M. Rich, Kennedy E. Okhawere, Charles Nguyen, et al. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.004.
Wan S; Li KP; Yang L
Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37722953
[No Abstract] [Full Text] [Related]
37. Re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023.
Wang Z; Zeng S; Xu C
Eur Urol; 2024 Apr; 85(4):e113-e114. PubMed ID: 37919193
[No Abstract] [Full Text] [Related]
38. Re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023.
Inamura K
Eur Urol; 2024 Apr; 85(4):e120-e121. PubMed ID: 37696739
[No Abstract] [Full Text] [Related]
39. Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Vickers AJ
Eur Urol; 2024 May; ():. PubMed ID: 38797599
[No Abstract] [Full Text] [Related]
40. Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Stroomberg HV; Brasso K; Røder A
Eur Urol; 2024 May; ():. PubMed ID: 38749855
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
